Subsequently, these expressed antigens bind to the MHC on the surface of APCs and are presented to T lymphocytes, activating CD4+ and CD8+ T lymphocytes, which then proceed to eliminate tumor cells (Figure 6). The gene discussed is CD8A; the disease is neoplasm.